Log in to save to my catalogue

Oral drugs in the treatment of metastatic colorectal cancer

Oral drugs in the treatment of metastatic colorectal cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_344cd31c70874b66a91affaa308d000e

Oral drugs in the treatment of metastatic colorectal cancer

About this item

Full title

Oral drugs in the treatment of metastatic colorectal cancer

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Medical Oncology, 2021, Vol.13, p.17588359211009001

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Colorectal cancer (CRC) is one of the most common forms of cancer, with an estimated 1.36 million new cases and almost 700,000 deaths annually. Approximately 21% of patients with CRC have metastatic disease at diagnosis. The objective of this article is to review the literature on the efficacy and safety of oral drugs available for the treatment of...

Alternative Titles

Full title

Oral drugs in the treatment of metastatic colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_344cd31c70874b66a91affaa308d000e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_344cd31c70874b66a91affaa308d000e

Other Identifiers

ISSN

1758-8359,1758-8340

E-ISSN

1758-8359

DOI

10.1177/17588359211009001

How to access this item